111, Inc. is a leading digital and mobile healthcare platform in China, offering comprehensive healthcare solutions utilizing advanced technology and integrated online and offline platforms. Founded in 2010, the company focuses on online medical services and pharmacies through a highly optimized supply chain and resource allocation.
The core business segments of 111, Inc. include the online B2C pharmacy platform 1 Drugstore, the Internet hospital 1 Clinic, and the online B2B pharmacy platform 1 Drug Mall. Their mission is to create the largest integrated online and offline healthcare platform in China, driven by technology through a B2B2C business model. As of 01 November 2015, the company received a significant $188.00M Series D investment from Verlinvest and Wuhan Tianying Investment Group.
Recognized as one of the few unicorns in the Internet medical health industry, 111, Inc. is committed to delivering innovative healthcare solutions to the Chinese population by leveraging the power of advanced Internet and information technology.
